Erlotinib/gefitinibHair and scalp changes: 13 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2013年 / 1470卷 / 1期

关键词：

D O I：

10.1007/s40278-013-5977-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：21 / 21

相关论文

共 50 条

[31] Erlotinib/panitumumabVarious skin toxicities: 2 case reports
Reactions Weekly, 2019, 1748 (1) : 201 - 201
[32] Erlotinib/gefitinibAcneiform eruptions and eruptions: 2 case reports
Reactions Weekly, 2015, 1544 (1) : 104 - 104
[33] Bevacizumab/erlotinib/pembrolizumabVarious toxicities: 9 case reports
Reactions Weekly, 2021, 1879 (1) : 74 - 74
[34] Erlotinib/gefitinibPapulopustular eruption and alopecia: 2 case reports
Reactions Weekly, 2018, 1717 (1) : 130 - 130
[35] Erlotinib/gefitinibRadiation recall pneumonitis: 7 case reports
Reactions Weekly, 2017, 1676 (1) : 128 - 128
[36] Cetuximab/erlotinib/gefitinibAcneiform eruptions: 8 case reports
Reactions Weekly, 2011, 1335 (1) : 14 - 14
[37] Multiple drugsPsoriatic alopecia of scalp: 3 case reports
Reactions Weekly, 2018, 1695 (1) : 270 - 270
[38] ImiquimodErosive pustular dermatosis of the scalp: 2 case reports
Reactions Weekly, 2019, 1744 (1) : 152 - 152
[39] CeftazidimeHypersensitivity: 13 case reports
Reactions Weekly, 1997, 658 (1) : 6 - 6
[40] CeftriaxonePseudolithiasis: 13 case reports
Reactions Weekly, 2021, 1861 (1) : 93 - 93

← 1 2 3 4 5 →